Brighten show already on insulin resistance
GLP-1RAs not only have the potential to treat the above-mentioned diseases but also ameliorate the co-morbidities simultaneously, which is important for patients with autoimmune/autoinflammatory diseases combined with metabolic diseases
Mild side effects Examples of the most common mild side effects that can occur with both Humalog and Humulin (when taken individually) include: injection site reactions, such as pain, redness, itchiness, or swelling around the area of your injection lipodystrophy (skin thickening or pitting around the injection site) rash itching swelling of your feet or ankles weight gain Serious side effects Examples of serious side effects that can occur with both Humalog and Humulin (when taken individually) include: hypoglycemia (low blood sugar) severe allergic reaction hypokalemia (a low level of potassium in your blood) Effectiveness Humalog and Humulin are both FDA-approved to treat type 1 and type 2 diabetes
This adds nuance to the CagriSema vs retatrutide research picture
Medical records, prescription history, diagnostic testing, and physician evaluations are often used to determine whether a person may have a viable claim connected to GLP-1 medication use
Dosing closer than 3 hours apart will not provide improved benefit
